Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first‐line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial

Francisco‐Javier Peñalver; José‐Antonio Márquez; Soledad Durán; Pilar Giraldo; Alejandro Martín; Carlos Montalbán; Juan‐Manuel Sancho; María‐José Ramírez; María‐José Terol; Francisco‐Javier Capote; Antonio Gutiérrez; Blanca Sánchez; Andrés López; Antonio Salar; Gil Rodríguez‐Caravaca; Miguel Canales; María‐Dolores Caballero;

doi:10.1002/cam4.2555

Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first‐line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial

Cancer Medicine ◽

10.1002/cam4.2555 ◽

2019 ◽

Vol 8 (16) ◽

pp. 6955-6966 ◽

Cited By ~ 1

Author(s):

Francisco‐Javier Peñalver ◽

José‐Antonio Márquez ◽

Soledad Durán ◽

Pilar Giraldo ◽

Alejandro Martín ◽

...

Keyword(s):

Follicular Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

Rituximab Maintenance

Download Full-text

5.40 Rituximab Maintenance in Patients with Chronic Lymphocytic Leukemia after First-Line Treatment with Rituximab plus Fludarabine, Cyclophosphamide, and Mitoxantrone: Final Results of a Multicenter Phase II Trial on Behalf of the Spanish CLL Study Group (GELLC)

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2011.09.194 ◽

2011 ◽

Vol 11 ◽

pp. S270-S272

Author(s):

Francesc Bosch ◽

Pau Abrisqueta ◽

Neus Villamor ◽

María José Terol ◽

Eva González-Barca ◽

...

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Phase Ii ◽

Phase Ii Trial ◽

Lymphocytic Leukemia ◽

Study Group ◽

Line Treatment ◽

First Line ◽

Rituximab Maintenance ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

Phase II trial of rituximab and short duration chemotherapy followed by 90Y-ibritumomab tiuxetan as first-line treatment for patients with follicular lymphoma: A Minnie Pearl Cancer Research Network phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.6519 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6519-6519 ◽

Cited By ~ 10

Author(s):

D. L. Shipley ◽

D. R. Spigel ◽

D. L. Carrell ◽

C. Dannaher ◽

F. A. Greco ◽

...

Keyword(s):

Cancer Research ◽

Follicular Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Research Network ◽

Line Treatment ◽

First Line ◽

Ibritumomab Tiuxetan ◽

Cancer Research Network ◽

First Line Treatment

Download Full-text

Phase II trial of rituximab and short duration chemotherapy followed by 90Y-ibritumomab tiuxetan as first-line treatment for patients with follicular lymphoma: A Minnie Pearl Cancer Research Network phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.6519 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6519-6519 ◽

Cited By ~ 2

Author(s):

D. L. Shipley ◽

D. R. Spigel ◽

D. L. Carrell ◽

C. Dannaher ◽

F. A. Greco ◽

...

Keyword(s):

Cancer Research ◽

Follicular Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Research Network ◽

Line Treatment ◽

First Line ◽

Ibritumomab Tiuxetan ◽

Cancer Research Network ◽

First Line Treatment

Download Full-text

Faculty Opinions recommendation of A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697918.793457734 ◽

2012 ◽

Author(s):

Hans-Joachim Schmoll

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

Dose Dense ◽

First Line Treatment

Download Full-text

Faculty Opinions recommendation of Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717953623.793459233 ◽

2012 ◽

Author(s):

Nicolas Mounier

Keyword(s):

Targeted Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

Chlamydophila Psittaci

Download Full-text

Switch Maintenance Gemcitabine after First Line Chemotherapy in Patients with Malignant Mesothelioma: A Randomized Open Label Phase II Trial (NVALT19)

SSRN Electronic Journal ◽

10.2139/ssrn.3520057 ◽

2020 ◽

Author(s):

Cornedine J. de Gooijer ◽

Vincent van der Noort ◽

Jos A. Stigt ◽

Paul Baas ◽

Bonne Biesma ◽

...

Keyword(s):

Phase Ii ◽

Malignant Mesothelioma ◽

Phase Ii Trial ◽

First Line ◽

Open Label ◽

Open Label Phase ◽

Line Chemotherapy

Download Full-text

Phase II trial of bevacizumab with carboplatin and dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.01.194 ◽

2015 ◽

Vol 137 ◽

pp. 79

Author(s):

N.D. Fleming ◽

R.L. Coleman ◽

C.S. Tung ◽

M.F. Munsell ◽

A.K. Sood

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Line Treatment ◽

First Line ◽

Dose Dense ◽

First Line Treatment

Download Full-text

UPDATED RESULTS OF THE FIL “MIRO” STUDY, A MULTICENTER PHASE II TRIAL COMBINING LOCAL RADIOTHERAPY AND MRD‐DRIVEN IMMUNOTHERAPY IN EARLY‐STAGE FOLLICULAR LYMPHOMA

Hematological Oncology ◽

10.1002/hon.31_2880 ◽

2021 ◽

Vol 39 (S2) ◽

Author(s):

A. Pulsoni ◽

M. E. Tosti ◽

S. Ferrero ◽

S. Luminari ◽

A. Dondi ◽

...

Keyword(s):

Follicular Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Early Stage ◽

Multicenter Phase

Download Full-text

P48.09 Anlotinib Plus Etoposide and Carboplatin as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: A Single Arm Phase II Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.879 ◽

2021 ◽

Vol 16 (3) ◽

pp. S503

Author(s):

B. Han ◽

W. Zhang ◽

B. Zhang ◽

Y. Chen ◽

Y. Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Extensive Stage ◽

First Line Treatment

Download Full-text

672 Randomised phase II trial (M77001) of trastuzumab (Herceptin®) plus docetaxel versus docetaxel alone, as first-line therapy in patients with HER2-positive metastitic breast cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90703-8 ◽

2003 ◽

Vol 1 (5) ◽

pp. S202 ◽

Cited By ~ 15

Author(s):

J.-M. Extra ◽

F. Cognetti ◽

S. Chan ◽

D. Maraninchi ◽

R. Snyder ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

Her2 Positive ◽

First Line Therapy ◽

Line Therapy

Download Full-text